載入...
AT-21 FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM)
BACKGROUND: PVSRIPO is the live attenuated, oral (SABIN) serotype 1 poliovirus vaccine containing a heterologous internal ribosomal entry site stemming from human rhinovirus type 2. PVSRIPO recognizes nectin-like molecule-5, an oncofetal cell adhesion molecule and tumor antigen widely expressed ecto...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Oxford University Press
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217799/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.21 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|